Lv1
20 积分 2024-04-28 加入
Receptor CDCP1 Is a Potential Target for Personalized Imaging and Treatment of Poor Outcome HER2+, Triple-Negative, and Metastatic ER+/HER2− Breast Cancers
3天前
已完结
CD318 expression defines a novel subset of human CD8 + regulatory T cells
13天前
已完结
SDP-LIV1, a Novel and Optimized LIV-1 Antibody–Drug Conjugate Demonstrating Superior Antitumor Efficacy and a Favorable Safety Profile for the Treatment of Solid Tumors
2个月前
已完结
Abstract 1838: LBL-024, an anti-PD-L1 and 4-1BB bispecific antibody with highly differentiated binding affinity, shows anti-tumor efficacy in a mouse tumor model
2个月前
已完结
HS-20093, a B7-H3-targeted antibody-drug conjugate in lung cancer: Results from the ARTEMIS-001 phase 1a/b trial
2个月前
已完结
High transcytosis of melanotransferrin (P97) across the blood–brain barrier
3个月前
已完结
A novel phage display vector for selection of target-specific peptides
4个月前
已完结
The Nonclinical Safety Assessment of a Novel Anti-CEACAM5 Antibody Exatecan Conjugate Predicts a Low Risk for Interstitial Lung Disease (ILD) in Patients—The Putative Mechanism Behind ILD
5个月前
已完结
OA06.02 Safety and Efficacy of QLC5508 in Previously Treated Patients with Small Cell Lung Cancer: Updated Data from a Phase 1 Study
5个月前
已关闭
Whole Cell Panning with Phage Display
5个月前
已完结
皖公网安备34019202002308
